Johan Westman

Biolin Scientific AB develops, manufactures, markets, and sells analytical instruments and related products. Its parent company involves in the discovery of drugs, develops solutions for energy and materials, and performs research at the frontiers of science and technology. The firm's customers include companies working with pharmaceuticals, energy, chemicals, and advanced materials, as well as academic and governmental research institutes. The company was founded on September 19, 1984 and is headquartered in Vastra Frolunda, Sweden.

Nanoxis AB provides tools and services for membrane protein research. It specializes in research and development of nanofabrication technologies in soft polymer and fluid-state liquid crystalline material. The company was founded by Owe Orwar and Anders Karlsson in November 2002 and is headquartered in Gothenburg, Sweden.

Millipore is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, they collaborate with customers to confront the world's challenging human health issues. From research through development to production, its scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals.

Part of IDEX Corp., Steridose AB is a Swedish company that specializes in the design and manufacture of aseptic valves and magnetic mixers for the pharmaceutical, biotech, and food industries. With over 30 years of experience, Steridose has established itself as a leading provider of high-quality, reliable, and innovative solutions for critical process applications. Steridose is committed to continuous improvement and invests heavily in research and development to stay at the forefront of its industry. The company's products are designed to meet the strictest regulatory requirements and are used by customers around the world to ensure the safety and efficacy of their products.

Arterion AB is a holding company that manufactures biomaterials, including artificial blood vessels, consisting of microbial derived cellulose for revascularization of patients with cardiovascular diseases. It focuses on pure uncoated cellulose grafts as replacement of human vessels, primarily as bypass grafts. Its manufacturing method is based on a novel technology that controls the life conditions of the microbe Gluconacetobacter xylinus. Its use of microbial derived cellulose will allow clinicians to use artificial blood vessels as replacement for vessels with an internal diameter of less than five millimeters. The company was founded on January 4, 2007 and is headquartered in Gothenburg, Sweden.

MIVAC Development AB develops treatment of autoimmune diseases and mucosal vaccine. The company was founded in 2008 and is headquartered in Goteborg, Sweden.